<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02081859</url>
  </required_header>
  <id_info>
    <org_study_id>14-090</org_study_id>
    <nct_id>NCT02081859</nct_id>
  </id_info>
  <brief_title>Use of Time-lapse Morphological Kinetics in the Selection of Blastocysts</brief_title>
  <acronym>Embryoscope</acronym>
  <official_title>Does Use of Time-lapse Morphological Kinetics in the Selection of Blastocysts for Transfer Improve Pregnancy Rates?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled observational trial to determine if data obtained from the
      embryoscope is helpful in determining which blastocysts to transfer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Materials and Methods:

      Patient Selection:

      Patients undergoing an IVF cycle at the Cleveland Clinic Reproductive Endocrinology and
      Infertility clinic with the plan for transfer of embryo(s) will be offered the opportunity to
      participate in this study. We would like a total enrollment 300 patients with 150 in each
      group. The only patients excluded will be those undergoing pre-implantation genetic testing
      and/or chromosome screening.

      Study Design This will be a prospective randomized controlled trial where all patients who
      agree to participate will be randomized to having embryo selection for transfer based solely
      on conventional criteria or alternatively conventional criteria in conjunction with
      morphokinetic criteria.

      Enrollment:

      Patients will be enrolled at the Beachwood IVF center by the REI physicians at the time of
      the IVF consultation. They will sign the informed consent for the study at the time that they
      sign the consent for IVF treatment, which is done by the IVF nurses. Informed consent for the
      study will be kept in the patient chart in the Beachwood IVF center along with the IVF
      consent.

      Randomization:

      Patients will be randomized 1:1 to Conventional embryo selection vs. Embryoscope selection
      using a computer generated random number sequence. Group assignment will be written on a
      piece of paper and placed in consecutively numbered opaque envelopes by research personnel
      not involved in embryo selection. Each patient randomized will be assigned the next
      consecutive number and the embryo selection criteria will be revealed at time of oocyte
      retrieval. Patients, REI physicians and staff, and sonographers will be blinded as to how
      embryos are selected. Only the embryologist and the lab staff will be aware of which group
      the patients are randomized into. This will be ensured by not placing the group in the
      computerized medical record or the clinical chart, but only in the laboratory chart and the
      research database.

      Sample Size Justification Little published data is available on time-lapse imaging and human
      embryo selection for transfer. No publications of randomized controlled trials are available
      on the EmbryoScope. Statistician Benjamin Nutter was consulted for sample size estimation.
      Initially, based on the 2012 outcomes there was a pregnancy rate of 49%. For a power of 80%,
      in order to detect an increase to 55% pregnancy rates under the new selection guidelines, we
      would need to randomize 1088 patients. To see an increase to 60% pregnancy rates, we would
      need to randomize 320 patients.

      In this study, we will be focusing on those patients who have blastocysts available for
      transfer since blastocysts are the embryos that we need the most assistance with selection.
      The pregnancy rate in this subset of patients is currently 70% and to detect an increase to
      80% would require randomization of 231 patients. Based on these numbers we feel it is
      reasonable to start with a goal of 300 patients in this study as there will be some patients
      that do not make it to retrieval, some that have no fertilization and some that have no
      embryos progress to transfer. Starting with a goal of 300 patients will hopefully give us a
      large enough sampling to do a preliminary analysis of embryos resulting in a clinically
      evident pregnancy as defined by positive fetal heart rate.

      Given that the outcome of this study is pregnancy rate we will assess the data collected
      after six months to evaluate if there is a clear difference between groups. If there is a
      significant difference at that time, the study may be terminated to allow for all patients to
      have the benefit of the superior method.

      Research Procedure The basic IVF laboratory protocols utilized will be the same as that used
      for all patients. Oocytes will be recovered by transvaginal aspiration of follicles under
      ultrasound guidance. Oocytes will be inseminated by intracytoplasmic sperm injection or
      co-incubation with sperm. The next morning, normally fertilized oocytes will be identified
      and moved to individual wells in a slide chamber and placed in the EmbryoScope.

      Those randomized to classic evaluation will have their embryos graded based on conventional
      daily evaluation at specified daily time points. These criteria encompass timely development
      to specific benchmarks at 20, 26, 44, 68, 92, 116 and 140 hours post-insemination.

      The images will be from the EmbryoScope, but will be static in time and will not span across
      a time range. Embryos will be graded and selected for transfer according to the laboratory's
      conventional criteria. Those randomized to classic evaluation plus morphokinetic parameters
      will have embryo evaluation performed at the same defined intervals but using the data
      analysis software and the captured time-lapse images to include timing of mitotic intervals,
      cleavage planes, timing of compaction and cavitation in embryos leading to blastocyst
      formation.

      Patients electing not to participate in the study would still have their embryos cultured in
      the EmbryoScope and conventional embryo selection criteria would be applied to identify
      embryos fro transfer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patients will have a ultrasound to document fetal heart rate approximately 6 weeks after start of IVF cycle.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation Rate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Percent of embryos implanted assessed at time of ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Viability</condition>
  <arm_group>
    <arm_group_label>Conventional grading</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Embryos will be scored based on conventional criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Embryoscope data</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Embryos will be scored based on both conventional rating and embryoscope data.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Embryoscope</intervention_name>
    <description>The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
    <arm_group_label>Embryoscope data</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Criteria</intervention_name>
    <arm_group_label>Conventional grading</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients undergoing an IVF cycle between the age of 18-45 at the Cleveland Clinic
        Reproductive Endocrinology and Infertility clinic with the plan for transfer of embryo(s)
        will be offered the opportunity to participate in this study.

        Exclusion Criteria:

        The only patients excluded will be those undergoing pre-implantation genetic testing and/or
        chromosome screening.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina Desai, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Beachwood Family Health Center</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2014</study_first_posted>
  <results_first_submitted>February 6, 2017</results_first_submitted>
  <results_first_submitted_qc>April 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 15, 2017</results_first_posted>
  <last_update_submitted>May 15, 2017</last_update_submitted>
  <last_update_submitted_qc>May 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Conventional Grading</title>
          <description>Embryos will be scored based on conventional criteria.
Conventional Criteria</description>
        </group>
        <group group_id="P2">
          <title>Embryoscope Data</title>
          <description>Embryos will be scored based on both conventional rating and embryoscope data.
Embryoscope: The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="150"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
                <participants group_id="P2" count="119"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No fertilization</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No sperm</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unanticipated freeze all cycle</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>&lt; 4 embryos</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other reasons</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Conventional Grading</title>
          <description>Embryos will be scored based on conventional criteria.
Conventional Criteria</description>
        </group>
        <group group_id="B2">
          <title>Embryoscope Data</title>
          <description>Embryos will be scored based on both conventional rating and embryoscope data.
Embryoscope: The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="116"/>
            <count group_id="B2" value="119"/>
            <count group_id="B3" value="235"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.2" spread="3.9"/>
                    <measurement group_id="B2" value="33.6" spread="4"/>
                    <measurement group_id="B3" value="33.3" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="235"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparous</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Length of infertility</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.5" spread="22.4"/>
                    <measurement group_id="B2" value="31.4" spread="22.4"/>
                    <measurement group_id="B3" value="31.5" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>AMH</title>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.5" spread="3.2"/>
                    <measurement group_id="B2" value="3.7" spread="4.2"/>
                    <measurement group_id="B3" value="3.6" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean embryo transferred</title>
          <units>embryo</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.9" spread="0.6"/>
                    <measurement group_id="B2" value="2.0" spread="0.5"/>
                    <measurement group_id="B3" value="1.95" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Pregnancy Rate</title>
        <description>Patients will have a ultrasound to document fetal heart rate approximately 6 weeks after start of IVF cycle.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional Grading</title>
            <description>Embryos will be scored based on conventional criteria.
Conventional Criteria</description>
          </group>
          <group group_id="O2">
            <title>Embryoscope Data</title>
            <description>Embryos will be scored based on both conventional rating and embryoscope data.
Embryoscope: The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Pregnancy Rate</title>
          <description>Patients will have a ultrasound to document fetal heart rate approximately 6 weeks after start of IVF cycle.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Implantation Rate</title>
        <description>Percent of embryos implanted assessed at time of ultrasound</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional Grading</title>
            <description>Embryos will be scored based on conventional criteria.
Conventional Criteria</description>
          </group>
          <group group_id="O2">
            <title>Embryoscope Data</title>
            <description>Embryos will be scored based on both conventional rating and embryoscope data.
Embryoscope: The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
          </group>
        </group_list>
        <measure>
          <title>Implantation Rate</title>
          <description>Percent of embryos implanted assessed at time of ultrasound</description>
          <units>Percentage of embryos</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.2"/>
                    <measurement group_id="O2" value="51.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.21</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <desc>All cause mortality and adverse events were not collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>Conventional Grading</title>
          <description>Embryos will be scored based on conventional criteria.
Conventional Criteria</description>
        </group>
        <group group_id="E2">
          <title>Embryoscope Data</title>
          <description>Embryos will be scored based on both conventional rating and embryoscope data.
Embryoscope: The embryoscope is a microscope that allows for continuous time-lapse monitoring.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <description>Embryos were scored based on conventional criteria. No adverse events reported.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lynn Borzi (Research Administrator)</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-445-3158</phone>
      <email>BORZIL@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

